{"id":56427,"date":"2026-02-05T20:56:40","date_gmt":"2026-02-05T12:56:40","guid":{"rendered":"https:\/\/flcube.com\/?p=56427"},"modified":"2026-02-05T20:56:41","modified_gmt":"2026-02-05T12:56:41","slug":"meditrust-mabwell-insurance-ecosystem-partnership","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=56427","title":{"rendered":"MediTrust Mabwell Insurance Ecosystem Partnership"},"content":{"rendered":"\n

Shanghai MediTrust Health Technology Group Co., Ltd.<\/strong> (a subsidiary of Shanghai Pharmaceuticals) announced a comprehensive strategic collaboration with Mabwell (Shanghai) Bioscience Co., Ltd.<\/strong> (SHA: 688062<\/a>) to create a closed\u2011loop “internet + healthcare + medicine + insurance”<\/strong> service ecosystem. The partnership aims to enhance patient access to and affordability of innovative drugs while alleviating financial burden.<\/p>\n\n\n\n

Partnership Structure & Strategic Scope<\/h2>\n\n\n\n
Item<\/th>Detail<\/th><\/tr><\/thead>
Companies<\/strong><\/td>MediTrust Health Technology (Shanghai Pharma subsidiary) \/ Mabwell Bioscience (688062.SH)<\/td><\/tr>
Core Infrastructures<\/strong><\/td>Diversified drug payment platform, pharmaceutical supply chain, AI intelligence hub<\/td><\/tr>
Product Portfolio<\/strong><\/td>Autoimmunity, bone health, oncology (Mabwell)<\/td><\/tr>
Key Platforms<\/strong><\/td>One\u2011Click Direct Payment (user service platform), intelligent pharmaceutical commercialization solutions<\/td><\/tr>
Service Integration<\/strong><\/td>Online diagnosis\/appointment scheduling, disease education, chronic disease management, rehabilitation care<\/td><\/tr>
Strategic Goal<\/strong><\/td>Create end\u2011to\u2011end ecosystem spanning entire drug lifecycle; establish standardized medication habits<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Market Impact & Service Innovation<\/h2>\n\n\n\n